Add BrightSurf on Google Email

Science News for December 28, 2007


Cost of glaucoma medications may impact treatment

The management of glaucoma costs the US healthcare system approximately $2.5 billion per year, with glaucoma medications accounting for 38-52% of direct costs. Non-selective ß-blockers remain the most inexpensive class of glaucoma medications, while brand-name ß-blockers are consistently more expensive than their generic counterparts.

SourceElsevier Health Sciences·JournalAmerican Journal of Ophthalmology·DateDec 28, 2007

Men need more Botox than women

A review published in Dermatologic Therapy reveals that men need higher doses of Botox due to greater muscle mass, leading to inadequate results from under-dosing. The study suggests that larger, stronger men require more units per treatment area than slender, small-boned men.

SourceBlackwell Publishing Ltd.·JournalDermatologic Therapy·DateDec 28, 2007

Fortune 1000 IT investments are riskier than capital investments, says management insights

A recent study by Sanjeev Dewan, Charles Shi, and Vijay Gurbaxani found that information technology (IT) investments are substantially riskier than ordinary capital investments. This increased risk is associated with a substantial risk premium, driven in part by the lost option value of making irreversible capital investment decisions.